EEEsra Ekinci

Esra Ekinci

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Esra Ekinci has a total of 41 co-authors. Here are the top co-authors by number of shared publications:

  • Heidi Theeten

    Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp

    6 shared publications
  • Philippe Beutels

    Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine and Infectious Disease Institute, University of Antwerp

    5 shared publications
  • Ine Wouters

    Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp , Wilrijk, Antwerp , Belgium

    4 shared publications
  • Liesbet Van Heirstraeten

    Centre for the Evaluation of Vaccination, University of Antwerp, Wilrijk, Belgium

    4 shared publications
  • Jan Verhaegen

    Reference Centre for Pneumococci, University Hospitals Leuven , Leuven , Belgium

    3 shared publications
  • Laura Willen

    Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp

    3 shared publications

Latest Publications

  • Open Access

    Pneumococcal genotype 23B1 as a driver of increased 23B serotype carriage, penicillin non-susceptibility, and invasive disease in Belgium: a retrospective analysis

    by Lara Dierckx, Juan Pablo Rodriguez-Ruiz, Esra Ekinci, Liesbet van Heirstraeten, Laura Willen, Lize Cuypers, Philippe Beutels, Kirsten Maertens, Stefanie Desmet, Heidi Theeten, et al.

    Streptococcus pneumoniae serotype 23B, a non-vaccine serotype, has shown an increasing prevalence and penicillin non-susceptibility among carriage and invasive pneumococcal disease (IPD) isolates. Recently, a novel penicillin non-susceptible genotype has emerged, named 23B1. In the framework of the Belgian pneumococcal carriage study, we studied the prevalence of 23B 0 /23B1 among 586 23B strains (2016–2022) in 172 day care centers from 6- to 30-month-old children and among 130 pediatric 23B IPD isolates (2007–2021). Pneumococci were whole genome sequenced to determine the capsular polysaccharide genotype and sequence type (ST). Antimicrobial susceptibility testing determined penicillin and amoxicillin MICs, as well as resistance to co-trimoxazole and levofloxacin. 23B carriage was stable during 2016 ̶ 2022 except in the 2020–2021 winter season when it increased. The proportion of genotype 23B1 compared to 23B 0 decreased from 2016 ̶ to 2022 but remained consistently higher than 23B 0 . In 2020–2021, an increase in the proportion of 23B1 was reflected in an overall increase in 23B carriage. All increases in 23B IPD cases were almost entirely driven by 23B1. The median penicillin MICs were significantly different for 23B 0 (0.03 mg/L) and 23B1 (0.25 mg/L). In 2021, increased intermediate levofloxacin susceptibility was noted in 23B. 23B1-associated ST2372 was the most prevalent ST in carriage and IPD during 2013–2022. We show that an increase in 23B carriage among children was paralleled in pediatric IPD in Belgium, reiterating the utility of pneumococcal surveillance in the day care population. Serotype 23B is reported worldwide as an important pediatric non-PCV13 serotype with reduced penicillin susceptibility, with 23B1 as the presumed driver for the increased prevalence. IMPORTANCE: During the COVID-19 pandemic, the 23B serotype of Streptococcus pneumoniae has increased in prevalence in healthy carriage isolates from Belgian day care centers and pediatric (younger than 18 years of age) invasive pneumococcal disease (IPD) isolates. Additionally, an increase in penicillin non-susceptibility was also observed within this serotype. Recently, a genetic variant of 23B, named 23B1, was discovered, which is known to be related to decreased penicillin susceptibility. We showed that increases in 23B prevalence in healthy carriage and IPD cases always coincided with 23B1 expansions, leading to higher penicillin non-susceptibility rates. Increases in 23B in the day care population paralleled pediatric 23B IPD increases, indicating the vital role of day care monitoring of pneumococcal carriage. Countries should stay vigilant for prevalence increases in S. pneumoniae serotype 23B, given the decreased susceptibility to penicillin and co-trimoxazole of the 23B1 variant.


  • Nasopharyngeal carriage of Haemophilus influenzae, Streptococcus pneumoniae, SARS-CoV-2 and other common pathogens in infants attending daycare centers in context of the changes in the pediatric vaccination program in Belgium

    by Esra Ekinci

    The overall objective of this thesis is to acquire more insight on the impact of different pneumococcal vaccines as well as the effect of the switches made in the pediatric pneumococcal vaccination program on pneumococcal carriage in the target group. The carriage of Streptococcus pneumoniae was therefore monitored in Belgian children between six and thirty months of age to determine the carriage prevalence, serotype distribution, antimicrobial susceptibility, and risk factors for carriage over the monitoring period. Also, the presence of common co-colonizers potentially causing respiratory infections was studied. To get more insight into the overall objective, different topics are investigated. Firstly, data on children suffering from acute otitis media (AOM), followed by the carriage of Haemophilus influenzae and SARS-CoV-2 are investigated in young children in Belgium.

  • Open Access

    Haemophilus influenzae carriage and antibiotic resistance profile in Belgian infants over a three-year period (2016–2018)

    by Esra Ekinci, Laura Willen, Juan Pablo Rodriguez Ruiz, Kirsten Maertens, Liesbet Van Heirstraeten, Gabriela Serrano, Magali Wautier, Ariane Deplano, Herman Goossens, Pierre Van Damme, et al.

    Background: Non-typeable Haemophilus influenzae has become increasingly important as a causative agent of invasive diseases following vaccination against H. influenzae type b. The emergence of antibiotic resistance underscores the necessity to investigate typeable non-b carriage and non-typeable H. influenzae (NTHi) in children.Methods: Nasopharyngeal swab samples were taken over a three-year period (2016–2018) from 336 children (6–30 months of age) attending daycare centers (DCCs) in Belgium, and from 218 children with acute otitis media (AOM). Biotype, serotype, and antibiotic resistance of H. influenzae strains were determined phenotypically. Mutations in the ftsI gene were explored in 129 strains that were resistant or had reduced susceptibility to beta-lactam antibiotics. Results were compared with data obtained during overlapping time periods from 94 children experiencing invasive disease.Results: Overall, NTHi was most frequently present in both carriage (DCC, AOM) and invasive group. This was followed by serotype “f” (2.2%) and “e” (1.4%) in carriage, and “b” (16.0%), “f” (11.7%), and “a” (4.3%) in invasive strains. Biotype II was most prevalent in all studied groups, followed by biotype III in carriage and I in invasive strains. Strains from both groups showed highest resistance to ampicillin (26.7% in carriage vs. 18.1% in invasive group). A higher frequency of ftsI mutations were found in the AOM group than the DCC group (21.6 vs. 14.9% – p = 0.056). Even more so, the proportion of biotype III strains that carried a ftsI mutation was higher in AOM compared to DCC (50.0 vs. 26.3% – p < 0.01) and invasive group.Conclusion: In both groups, NTHi was most frequently circulating, while specific encapsulated serotypes for carriage and invasive group were found. Biotypes I, II and III were more frequently present in the carriage and invasive group. The carriage group had a higher resistance-frequency to the analyzed antibiotics than the invasive group. Interestingly, a higher degree of ftsI mutations was found in children with AOM compared to DCC and invasive group. This data helps understanding the H. influenzae carriage in Belgian children, as such information is scarce.


  • Open Access

    Serotype 19A and 6C Account for One-Third of Pneumococcal Carriage Among Belgian Day-Care Children Four Years After a Shift to a Lower-Valent PCV

    by Esra Ekinci, Liesbet Van Heirstraeten, Laura Willen, Stefanie Desmet, Ine Wouters, Helene Vermeulen, Christine Lammens, Herman Goossens, Pierre Van Damme, Jan Verhaegen, et al.

    Pneumococcal conjugate vaccines (PCVs) effectively reduce infection and asymptomatic carriage of Streptococcus pneumoniae vaccine serotypes. In 2016, Belgium replaced its infant PCV13 program by a 4-year period of PCV10. Concomitantly, S. pneumoniae serotype carriage was monitored together with the carriage of other nasopharyngeal pathogens in children attending day-care centers. From 2016 to 2019, a total of 3459 nasopharyngeal swabs were obtained from children aged 6–30 months. Culture and qPCR were used for the identification of S. pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus and for serotyping and antimicrobial susceptibility assessment of S. pneumoniae strains. S. pneumoniae colonization was frequent and stable over the study years. H. influenzae and M. catarrhalis were more frequently carried (P < .001) than S. pneumoniae, by, respectively, 92.3% and 91.0% of children. Prevalence of all PCV13 serotypes together increased significantly over time from 5.8% to 19.6% (P < .001) and was attributable to the increasing prevalence of serotype 19A. Coincidently, non-vaccine serotype 6C increased (P < .001) and the overall pneumococcal non-susceptibility to tetracycline and erythromycin. Non-susceptibility to cotrimoxazole decreased (P < .001). The switch to a PCV program no longer covering serotypes 19A, 6A, and 3 was associated with a sustained increase of serotypes 19A and 6C in healthy children, similarly as in invasive pneumococcal disease. This resulted in a re-introduction of the 13-valent conjugate vaccine during the summer of 2019.


  • Open Access

    Streptococcus pneumoniae Serotypes Carried by Young Children and Their Association With Acute Otitis Media During the Period 2016–2019

    by Esra Ekinci, Stefanie Desmet, Liesbet Van Heirstraeten, Colette Mertens, Ine Wouters, Philippe Beutels, Jan Verhaegen, Surbhi Malhotra-Kumar, Heidi Theeten

    Background:Streptococcus pneumoniae(Sp) is a major cause of acute otitis media (AOM). Pneumococcal conjugate vaccine (PCV) programs have altered pneumococcal serotype epidemiology in disease and carriage. In this study, we used samples collected during a cross-sectional study to examine if the clinical picture of acute otitis media (AOM) in young children exposed to the PCV program in Belgium was related to the carried pneumococcal strains, and if their carriage profile differed from healthy children attending daycare centers.Material/Methods:In three collection periods from February 2016 to May 2018, nasopharyngeal swabs and background characteristics were collected from children aged 6–30 months either presenting at their physician with AOM (AOM-group) or healthy and attending day care (DCC-group). Clinical signs of AOM episodes and treatment schedule were registered by the physicians. Sp was detected, quantified, and characterized using both conventional culture analysis and real-time PCR analysis.Results:Among 3,264 collected samples, overall pneumococcal carriage and density were found at similar rates in both AOM and DCC. As expected non-vaccine serotypes were most frequent: 23B (AOM: 12.3%; DCC: 17.4%), 11A (AOM: 7.5%; DCC: 7.4%) and 15B (AOM: 7.5%; DCC: 7.1%). Serotypes 3, 6C, 7B, 9N, 12F, 17F, and 29 were more often found in AOM than in DCC (p-value < 0.05), whereas 23A and 23B were less often present in AOM (p-value < 0.05). Antibiotic non-susceptibility of Sp strains was similar in both groups. No predictors of AOM severity were identified.Conclusion:In the present study, overall carriage prevalence and density ofS. pneumoniaewere found similar in young children with AOM and in healthy children attending day-care centers in Belgium. Certain serotypes not currently included in the PCV vaccines were found to be carried more often in children with AOM than in DCC, a finding that might suggest a relationship between these serotypes and AOM.


  • Open Access

    No SARS‐CoV‐2 carriage observed in children attending daycare centers during the intial weeks of the epidemic in Belgium

    by Stefanie Desmet, Esra Ekinci, Ine Wouters, Bram Decru, Kurt Beuselinck, Surbhi Malhotra‐Kumar, Heidi Theeten

    To gain knowledge about the role of young children attending daycare in the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) epidemic, a random sample of children (n = 84) aged between 6 and 30 months attending daycare in Belgium was studied shortly after the start of the epidemic (February 29th) and before the lockdown (March 18th) by performing in‐house SARS‐CoV‐2 real‐time polymerase chain reaction. No asymptomatic carriage of SARS‐CoV‐2 was detected, whereas common cold symptoms were common (51.2%). Our study shows that in Belgium, there was no sign of early introduction into daycare centers at the moment children being not yet isolated at home, although the virus was clearly circulating. It is clear that more evidence is needed to understand the actual role of young children in the transmission of SARS‐CoV‐2 and their infection risk when attending daycare.


  • Open Access

    Streptococcus pneumoniae serotypes carried by young children and their association with Acute Otitis Media during the period 2016 – 2019

    by Esra Ekinci, Stefanie Desmet, Liesbet Van Heirstraeten, Colette Mertens, Ine Wouters, Philippe Beutels, Jan Verhaegen, Surbhi Malhotra-Kumar, Heidi Theeten

    Background: Streptococcus pneumoniae (Sp) is a major cause of acute otitis media (AOM). Pneumococcal conjugate vaccine (PCV) programs have altered pneumococcal serotype epidemiology in disease and carriage. To establish the clinical picture of AOM in young children exposed to the PCV program in Belgium and the Sp strains they carry, a cross-sectional study started in 2016. Material/methods: In three collection periods from February 2016 to May 2018, nasopharyngeal swabs and background characteristics were collected from children aged 6-30 months either presenting at their physician with AOM (AOM-group) or healthy and attending day care (DCC-group). Sp was detected, quantified, and characterized using both conventional culture and qPCR. Clinical signs of AOM episodes and treatment were registered by the physicians. Results: Among 3264 collected samples, overall pneumococcal carriage and density were similar in AOM (79.2% and 0.50 ×10 6 copies/μl) and DCC (77.5% and 0.42 ×10 6 copies/μl). Non-vaccine serotypes were most frequent: 23B (AOM: 12.3%; DCC: 17.4%), 11A (AOM: 7.5%; DCC: 7.4%) and 15B (AOM: 7.5%; DCC: 7.1%). Serotypes 3, 6C, 7B, 9N, 12F, 17F and 29 were more frequent in AOM than in DCC, whereas 23A and 23B frequencies were lower. Antibiotic susceptibility of Sp strains was similar in both groups . No predictors of AOM severity were identified, and 77.3% received an antibiotic prescription. Conclusion: Young children with AOM did not carry Sp more frequently or at higher load than healthy children in day care, but some ST were more frequent in AOM and are not included in the currently used vaccines.

  • Open Access

    Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium – a serial prospective cross-sectional nationwide study of residual samples (March – October 2020)

    by Sereina Herzog, Jessie De Bie, Steven Abrams, Ine Wouters, Esra Ekinci, Lisbeth Patteet, Astrid Coppens, Sandy De Spiegeleer, Philippe Beutels, Pierre Van Damme, et al.

    To assess the evolving SARS-CoV-2 seroprevalence and seroincidence related to the national lock-down in Belgium, a nationwide seroprevalence study, stratified by age, sex and region using 3000-4000 residual samples was performed during 7 periods between 30 March and 17 October 2020. Residual sera from ambulatory patients were analyzed for IgG antibodies against S1 proteins of SARS-CoV-2 with a semi-quantitative commercial ELISA. Weighted seroprevalence (overall, by age category and sex) and seroincidence during 7 consecutive periods were estimated for the Belgian population while accommodating test-specific sensitivity and specificity. The weighted overall seroprevalence initially increased from 1.8% (95% CrI 1.0-2.6) to 5.3% (95% CrI 4.2-6.4), implying a seroincidence of 3.4% (95% CrI 2.4-4.6) between the 1 st and 2 nd collection period over a period of 3 weeks during the lockdown period (start lockdown mid March 2020). Thereafter, seroprevalence stabilized, however, significant decreases are observed when comparing the 3 rd with the 5 th and also with the 6 th period resulting in negative seroincidence estimates after lockdown was lifted. We estimated for the last collection period mid October 2020 a weighted overall seroprevalence of 4.2% (95% CrI 3.1-5.2). During lockdown, an initial small but increasing fraction of the Belgian population showed serologically detectable signs of exposure to SARS-CoV-2, which did not further increase when confinement measures eased and full lockdown was lifted.


  • Open Access

    No SARS-CoV-2 carriage observed in children attending daycare centers during the first weeks of the epidemic in Belgium

    by Stefanie Desmet, Esra Ekinci, Ine Wouters, Bram Decru, Kurt Beuselinck, Surbhi Malhotra-Kumar, Heidi Theeten

    To gain knowledge about the role of young children attending daycare in the SARS-CoV-2 epidemic, a random sample of children (n=84) aged between 6 and 30 months attending daycare in Belgium was studied shortly after the start of the epidemic (February 29 th ) and before the lockdown (March 18 th ). No asymptomatic carriage of SARS-CoV-2 was detected, whereas common cold symptoms were common (51.2%).